- Avid Bioservices (NASDAQ:CDMO) is scheduled to announce Q1 earnings results on Monday, September 9th, after market close.
- The consensus EPS Estimate is -$0.04 (-33.3% Y/Y) and the consensus Revenue Estimate is $40.82M (+8.3% Y/Y).
- Over the last 2 years, CDMO has beaten EPS estimates 25% of the time and has beaten revenue estimates 75% of the time.
